Search Results - eric+j.+sundberg

2 Results Sort By:
Engineering Asymmetrically Glycosylated IgG Antibodies
Application A novel method to develop asymmetrically glycosylated therapeutic monoclonal IgG antibodies for preventing and treating diseases like cancer, infectious diseases, and autoimmune disorders. Key Benefits Different IgG antibody glycoforms can be produced, each with its unique effector functions and biological and therapeutic effects. Potential...
Published: 5/30/2025   |   Inventor(s): Eric J. Sundberg, Jonathan Du, Tala Azzam
Keywords(s): Antibodies, Immunology and Inflammation Treatments, Microbiology and Infectious Disease Treatments, Oncology Treatments
Category(s): TechPub Algolia > Therapeutics
IgG-Specific Enzymes with Reduced Residual Glycan Hydrolysis
Application Novel enzymes for IgG-specific glycosynthesis. Key Benefits Nearly full glycosylation of IgG antibodies. Improved antibody-mediated effector function properties. No measurable residual hydrolysis activity. Market Summary The global monoclonal antibodies market is experiencing significant growth due to the rising prevalence of chronic...
Published: 5/30/2025   |   Inventor(s): Eric J. Sundberg, Jonathan Du, Tala Azzam
Keywords(s): Antibodies, Cardiovascular Treatments, Immunology and Inflammation Treatments, Oncology Treatments
Category(s): TechPub Algolia > Research Tools